Latest News and Press Releases
Want to stay updated on the latest news?
-
Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
-
Pluristyx & BioLamina partner to accelerate iPSC-based therapies with integrated cell culture solutions, for consistency, scalability & clinical success.
-
PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell...
-
Austin, TX, USA, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Induced Pluripotent Stem Cells Production Market Size, Trends and Insights By...
-
Century Therapeutics Reports Q2 2025 Results and Business Update
-
Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Stem Cell Culture Media Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities,...
-
Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" has been added to ResearchAndMarkets.com's offering....
-
Austin, TX, USA, April 03, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Induced Pluripotent Stem Cell iPSC Market Size, Trends and Insights By Derived...
-
Boston, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Induced Pluripotent Stem Cells: Global Markets is expected to reach $5.2 billion by the end of 2028, at a...
-
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's...